RT-403

N/A

Report date: 2023/03/10 14:59:15

Base Information

Drug NameRT-403
Drug Alias NameRT-403
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Royaltech Med Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLung NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A